Company page

Camurus Ab

Camurus AB is a public company listed on the Swedish market under the ticker CAMX. With a market capitalization of approximately 3.36 billion SEK, Camurus focuses on developing innovative medicines for patients with serious diseases. The company is committed to advancing its proprietary drug delivery technologies and expanding its product pipeline.